A detailed history of First Trust Advisors LP transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 327,782 shares of ALNY stock, worth $77.7 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
327,782
Previous 285,571 14.78%
Holding current value
$77.7 Million
Previous $78.6 Million 1.81%
% of portfolio
0.07%
Previous 0.08%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$232.27 - $300.43 $9.8 Million - $12.7 Million
42,211 Added 14.78%
327,782 $77.1 Million
Q3 2024

Nov 13, 2024

BUY
$233.81 - $287.01 $10.5 Million - $12.9 Million
45,024 Added 18.72%
285,571 $78.6 Million
Q2 2024

Aug 13, 2024

BUY
$143.31 - $247.0 $3.32 Million - $5.72 Million
23,174 Added 10.66%
240,547 $58.5 Million
Q1 2024

May 13, 2024

SELL
$146.51 - $198.2 $13.1 Million - $17.7 Million
-89,320 Reduced 29.12%
217,373 $32.5 Million
Q4 2023

Feb 13, 2024

BUY
$151.41 - $196.57 $11.1 Million - $14.4 Million
73,203 Added 31.35%
306,693 $58.7 Million
Q3 2023

Nov 13, 2023

SELL
$170.77 - $211.65 $7.32 Million - $9.08 Million
-42,886 Reduced 15.52%
233,490 $41.4 Million
Q2 2023

Aug 14, 2023

SELL
$185.01 - $212.05 $28.4 Million - $32.6 Million
-153,711 Reduced 35.74%
276,376 $52.5 Million
Q1 2023

May 15, 2023

BUY
$182.66 - $235.53 $1.74 Million - $2.24 Million
9,527 Added 2.27%
430,087 $86.2 Million
Q4 2022

Feb 09, 2023

SELL
$185.53 - $241.31 $13.8 Million - $17.9 Million
-74,372 Reduced 15.03%
420,560 $99.9 Million
Q3 2022

Nov 14, 2022

BUY
$138.54 - $232.0 $13.2 Million - $22.1 Million
95,067 Added 23.77%
494,932 $99.1 Million
Q2 2022

Aug 12, 2022

SELL
$120.42 - $169.29 $335,610 - $471,811
-2,787 Reduced 0.69%
399,865 $58.3 Million
Q1 2022

May 13, 2022

SELL
$127.18 - $173.91 $13.3 Million - $18.2 Million
-104,444 Reduced 20.6%
402,652 $65.7 Million
Q4 2021

Feb 08, 2022

SELL
$159.56 - $209.29 $4.02 Million - $5.27 Million
-25,190 Reduced 4.73%
507,096 $86 Million
Q3 2021

Nov 15, 2021

BUY
$169.75 - $207.73 $4.48 Million - $5.48 Million
26,363 Added 5.21%
532,286 $101 Million
Q2 2021

Aug 16, 2021

BUY
$128.63 - $176.89 $9.49 Million - $13.1 Million
73,793 Added 17.08%
505,923 $85.8 Million
Q1 2021

May 14, 2021

SELL
$126.83 - $175.69 $16.6 Million - $22.9 Million
-130,495 Reduced 23.19%
432,130 $61 Million
Q4 2020

Feb 02, 2021

SELL
$122.97 - $147.0 $20 Million - $24 Million
-162,987 Reduced 22.46%
562,625 $73.1 Million
Q3 2020

Nov 05, 2020

SELL
$121.19 - $165.49 $10.2 Million - $13.9 Million
-83,954 Reduced 10.37%
725,612 $106 Million
Q2 2020

Jul 22, 2020

SELL
$104.21 - $156.44 $3.93 Million - $5.89 Million
-37,668 Reduced 4.45%
809,566 $120 Million
Q1 2020

May 06, 2020

BUY
$93.12 - $133.99 $23.2 Million - $33.4 Million
249,019 Added 41.63%
847,234 $92.2 Million
Q4 2019

Feb 03, 2020

SELL
$74.51 - $124.23 $15.3 Million - $25.5 Million
-205,451 Reduced 25.56%
598,215 $68.9 Million
Q3 2019

Nov 04, 2019

SELL
$70.9 - $87.82 $24.8 Million - $30.7 Million
-349,574 Reduced 30.31%
803,666 $64.6 Million
Q2 2019

Jul 30, 2019

SELL
$65.86 - $92.79 $2.59 Million - $3.64 Million
-39,255 Reduced 3.29%
1,153,240 $83.7 Million
Q1 2019

May 09, 2019

BUY
$72.76 - $93.45 $1.05 Million - $1.35 Million
14,439 Added 1.23%
1,192,495 $111 Million
Q4 2018

Feb 07, 2019

BUY
$62.67 - $88.33 $15.1 Million - $21.3 Million
241,031 Added 25.72%
1,178,056 $85.9 Million
Q3 2018

Oct 25, 2018

BUY
$87.52 - $122.67 $24.3 Million - $34 Million
277,259 Added 42.02%
937,025 $82 Million
Q2 2018

Aug 02, 2018

BUY
$88.31 - $107.8 $10.9 Million - $13.3 Million
123,099 Added 22.94%
659,766 $65 Million
Q1 2018

Apr 23, 2018

SELL
$115.92 - $148.54 $4.03 Million - $5.16 Million
-34,731 Reduced 6.08%
536,667 $63.9 Million
Q4 2017

Feb 08, 2018

SELL
$114.49 - $139.98 $24.4 Million - $29.8 Million
-213,221 Reduced 27.18%
571,398 $72.6 Million
Q3 2017

Oct 24, 2017

BUY
$72.53 - $118.27 $56.9 Million - $92.8 Million
784,619
784,619 $92.2 Million

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $29.2B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.